How to Prosecute a Chemical Patent in the Netherlands (and at the EPO), Step-by-step (2026)

If you are developing a novel chemical compound, formulation or process and need to secure patent protection in the Netherlands or across Europe, understanding how to prosecute a chemical patent in the Netherlands, and at the European Patent Office (EPO), is the essential first step. The chemical patent process in the Netherlands involves choices between a national filing via the Netherlands Patent Office (Octrooicentrum Nederland / RVO), a direct European patent application at the EPO, or a PCT application entering the European phase. Each route carries distinct cost, timeline and enforcement implications that have shifted materially in 2026 following updates to the EPO Guidelines, Dutch Patent Act proposals and Unified Patent Court (UPC) procedural clarifications.

This guide walks patent attorneys, in-house IP counsel, R&D managers and SMEs through every stage, from invention capture and drafting through prosecution, opposition and enforcement, with the document checklists, deadline tables and chemistry-specific disclosure strategies needed to act now.

Overview of the Chemical Patent Process in the Netherlands and at the EPO

Patent prosecution for chemical inventions in the Netherlands follows one of four principal routes, each suited to different commercial objectives and budgets.

• Route A, National Netherlands filing. File directly with Octrooicentrum Nederland (part of RVO, the Netherlands Enterprise Agency). This is the fastest path to a Dutch-only patent right. It suits SMEs or inventors whose commercial interest is limited to the Dutch market.
• Route B, Direct EPO filing. File a European patent application directly at the EPO, designating the Netherlands (and other EPC contracting states). This provides centralised prosecution and, after grant, a bundle of national patent rights validated in each designated state.
• Route C, PCT → European phase. File an international application under the Patent Cooperation Treaty (PCT), then enter the European phase at the EPO. This route defers significant costs and allows applicants to assess commercial potential before committing to European prosecution.
• Route D, Unitary patent + UPC enforcement. After grant of a European patent, request unitary effect to obtain a single patent right across participating EU member states. Enforcement then falls under the jurisdiction of the Unified Patent Court (UPC), offering pan-EU injunctive relief from a single action.

Multinational pharma and chemical companies typically choose Routes B or C for broad territorial coverage, while university spin-outs and early-stage companies may start with Route A and file a priority-claiming EPO or PCT application within the 12-month Paris Convention window. The 2026 EPO and UPC developments described later in this guide make the Route D unitary patent option increasingly attractive for applicants seeking cost-efficient, EU-wide protection.

Eligibility and Prerequisites for Chemical Patent Protection

Before entering the chemical patent process in the Netherlands or at the EPO, applicants must confirm that their invention meets the substantive requirements for patentability under the Rijksoctrooiwet 1995 (Dutch Patents Act) and, for European filings, the European Patent Convention (EPC).

Patentability requirements

A chemical invention must satisfy three core criteria: novelty (the invention has not been made available to the public before the priority date), inventive step (the invention is not obvious to a person skilled in the art), and industrial applicability (the invention can be made or used in any kind of industry). Mere discoveries of naturally occurring substances, mathematical methods and aesthetic creations are excluded. However, a novel isolated compound with a demonstrated technical effect, or a new use of a known substance, is patentable provided the application discloses sufficient evidence of that effect.

Priority claims and the 12-month window

Under the Paris Convention, an applicant who files a first application in any Convention country has 12 months to file subsequent applications claiming priority. For chemical inventions this window is critical: experimental programmes often span months, and results generated after the priority filing may only be used to corroborate, not to establish, the technical effect. Applicants should therefore ensure the priority application contains enough experimental data to support the broadest claims they intend to pursue.

Novelty-preserving best practices for chemistry teams

Public disclosure of a compound or reaction scheme before filing destroys novelty. Conference posters, pre-prints, investor decks and even internal seminar slides shared externally can constitute prior art. Enforce confidentiality agreements with collaborators, restrict poster disclosures to general project outlines, and, if an inadvertent disclosure occurs, consider filing a provisional application immediately to limit damage.

How to Prosecute a Chemical Patent in the Netherlands: Step-by-Step Procedure

The following numbered steps trace the complete patent prosecution EPO timeline and the parallel national (NL) process, from pre-filing through to enforcement. The timeline table below summarises each stage, the responsible party and typical duration.

Step 1: Capture the invention and draft chemistry-specific claims

Begin by assembling all experimental data: reaction schemes, yields, characterisation (NMR, mass spectrometry, IR, HPLC), reproducibility results and structure confirmations. Claim drafting for chemical inventions typically involves three claim types: composition claims (the compound or formulation itself), process claims (the method of manufacture) and use claims (the technical application of the compound). For Markush-type claims, where a generic structure covers multiple substituents, include representative working examples for the key sub-groups to support sufficiency. Maintain dated, signed laboratory notebooks and a chain-of-custody record for all samples used in the examples. These documents are needed for the chemical patent filing and may become critical evidence during prosecution, opposition or litigation.

Step 2: Choose a filing route, national (NL) vs EPO vs PCT

The filing choice depends on territory, budget and commercial urgency. A national NL filing with Octrooicentrum Nederland is the quickest route to a Dutch patent right, with lower upfront costs of patent filing in the Netherlands, but it grants protection in the Netherlands only. A direct EPO filing initiates centralised prosecution and can yield validated patents in up to 39 EPC contracting states after grant. A PCT application defers costly national and regional phase entries by up to 31 months from the priority date, allowing time to evaluate commercial potential before committing.

Where broad EU coverage is the goal, consider requesting unitary effect after EPO grant, a decision that should be planned at filing stage because it affects claim scope and validation strategy. The 2026 Dutch Patent Act proposals may also affect national limitation and validity options (see the 2026 changes section below).

Step 3: Respond to EPO office actions and national examination communications

During prosecution, the EPO examiner will issue one or more examination reports raising objections on novelty, inventive step or sufficiency of disclosure. An EPO office action response is typically due within approximately four months of the communication date, although the precise period is set in each communication. Structured claim amendments, reasoned arguments and, particularly in chemistry, additional experimental data may be required. Post-filed data can be used at the EPO to corroborate an effect already made plausible in the application as filed, but it cannot serve as the sole basis for establishing inventive step. If the examiner’s objections persist, the applicant may request oral proceedings before the examining division.

At the Dutch national office (RVO), formalities examination is less substantive, but any third-party observations or objections must be addressed promptly to avoid delays.

Step 4: File divisional applications to preserve claim scope

A divisional application process at the EPO allows the applicant to carve out a separate application from a pending parent. This is a key tactical tool in chemistry: if the parent application faces narrowing amendments, a divisional can preserve broader or alternative claim sets, for example, product-by-process claims, composition claims with different ranges or second-medical-use claims. Divisionals must be filed while the parent is pending. Coordinate divisional timing with litigation counsel, because divisionals that are not opted out of the UPC may be exposed to central revocation proceedings.

Step 5: Receive grant, request unitary effect and manage opt-outs

After the EPO issues a decision to grant, the mention of grant is published in the European Patent Bulletin. At this point the proprietor faces two time-critical decisions. First, a request for unitary effect must be filed within one month after mention of grant, per the 2026 EPO Unitary Patent Guidelines. This converts the European patent into a unitary patent with uniform effect across participating EU member states. Second, the proprietor may register an opt-out from UPC jurisdiction if they prefer to enforce exclusively in national courts. The opt-out can be filed before or after grant, but it cannot be registered once UPC proceedings have been initiated.

Note that the nine-month EPO opposition window runs concurrently, so the proprietor should align opt-out and enforcement strategy with their opposition risk assessment.

Step 6: Navigate post-grant opposition at the EPO

Any third party (but not the patent proprietor) may file an opposition at the EPO within 9 months from the mention of grant in the European Patent Bulletin. The patent opposition procedure at the EPO requires the opponent to specify grounds, typically lack of novelty, lack of inventive step or insufficiency of disclosure, and to pay the official opposition fee. For chemical patents, opposition evidence strategies often include expert declarations, comparative testing data, re-analysis of the patent’s experimental examples, and prior-art searches targeting unpublished conference data or patent family documents. After the proprietor responds, the opposition division may schedule oral proceedings. The outcome can be maintenance of the patent (as granted or in amended form) or revocation.

Step 7: Choose an enforcement forum, national courts vs the UPC

Once a European patent (or unitary patent) is granted, the proprietor must decide where to enforce. The choice between national courts and UPC representation in patent litigation depends on several factors:

• Pan-EU relief. If the patent was not opted out, the UPC can grant injunctions, damages and declarations of non-infringement across all participating member states in a single action. This is attractive for chemical products sold in multiple EU markets.
• National-court advantages. Dutch courts (District Court The Hague) have deep experience in chemical and pharmaceutical patent disputes, and Dutch preliminary injunction proceedings can be faster than UPC procedures in certain circumstances. If the alleged infringement involves local chemical testing or manufacturing, national courts may be more convenient.
• Representation rules. Under Article 48 UPCA, parties before the UPC must be represented by a lawyer authorised to practise before a court of a contracting member state or by a European patent attorney who has appropriate qualifications and is registered on the UPC list. Check UPC Registrar guidance and registration requirements before assuming eligibility.
• Central revocation risk. A UPC revocation action can invalidate the patent across all participating states. If the patent’s validity is uncertain, an opt-out preserves national-only enforcement and limits revocation risk to one jurisdiction at a time.

The practical decision flow: assess validity strength, map the jurisdictions where infringement is occurring, evaluate the cost of UPC vs multi-country national proceedings, and confirm that qualified representation is available for the chosen forum.

Documents Needed for a Chemical Patent Filing

The documents needed for a chemical patent application, whether filed nationally in the Netherlands or at the EPO, must be assembled carefully. Chemistry-specific disclosure requirements are more demanding than in many other technology fields because examiners (and opponents) scrutinise whether the specification truly enables the skilled person to reproduce the claimed invention across its full scope.

Chemistry-specific disclosure checklist

• Working examples. Include at least two independent working examples for each key composition claim, demonstrating the invention at different points within the claimed range.
• Analytical characterisation. Provide NMR, mass spectrometry, IR and/or HPLC data with referenced raw files.
• Ranges and preferred embodiments. State numerical ranges explicitly and identify preferred sub-ranges; avoid aspirational language unsupported by data.
• Markush claims. Include representative sub-lists and a clear explanation of the selection rationale for each variable position.

Patent Prosecution EPO Timeline and Key Deadlines

Missing a deadline in patent prosecution can result in loss of rights that are difficult or impossible to recover. The table below consolidates the critical deadlines for the chemical patent process in the Netherlands and at the EPO.

Always calculate deadlines using calendar days and verify against the applicable office’s working-day calendar. Set internal deadlines two to three days ahead of the official deadline to allow for translation, signature and filing logistics. For chemistry-specific evidence, particularly post-filed comparative test data, allow an additional two to six weeks for generating standardised reports, depending on assay complexity. Industry observers expect that EPO processing times may fluctuate as the Office implements its 2026 workload management measures, so monitor published pendency statistics regularly.

Costs of Patent Filing in the Netherlands, at the EPO and Before the UPC

The costs of patent filing in the Netherlands and at the EPO vary significantly depending on the route, claim complexity and whether adversarial proceedings arise. The table below provides indicative fee ranges. All amounts should be verified against current official fee schedules before making budgetary commitments.

Tax considerations

The Netherlands offers R&D tax incentives (notably the WBSO scheme) that may offset a portion of development costs associated with the underlying research. However, these incentives do not directly reduce patent filing or prosecution fees. VAT treatment of patent attorney services follows standard Dutch rules. Applicants should consult a tax adviser to optimise the overall cost position of their IP programme.

What Changes in 2026: Dutch Patent Act Proposals and EPO/UPC Developments

The first half of 2026 has brought a wave of legislative and procedural changes affecting how to prosecute a chemical patent in the Netherlands and at the EPO. Practitioners should re-check authoritative sources regularly, as some proposals may still be progressing through the Dutch parliamentary process.

Dutch Patent Act proposals

Proposals under discussion in the Dutch parliament during early 2026 address enforcement procedures, evidence standards and limitation mechanisms under the Rijksoctrooiwet 1995. The likely practical effect for chemical patent holders will be heightened expectations around laboratory evidence and sampling protocols in infringement proceedings before Dutch courts. Early indications suggest that courts will increasingly require detailed chain-of-custody documentation for chemical samples presented as infringement evidence. Practitioners with active or anticipated enforcement matters should monitor official publications on the Netherlands, Intellectual Property practice page and government legislative registers for finalised statutory text.

EPO Guidelines 2026

The 2026 edition of the EPO Guidelines for Examination introduces updated guidance on divisional application practice, the handling of post-filed evidence in chemistry cases, and procedural aspects of the European phase entry under Rule 159 EPC. For chemical patent applicants, the most operationally significant update is the confirmed one-month deadline for requesting unitary effect after mention of grant, a tight window that demands pre-grant preparation of the necessary translations and administrative filings.

UPC representation and procedural clarifications

Clarifications issued in 2026 confirm that certain European patent attorneys may represent parties before the UPC provided they hold appropriate qualifications and are registered on the UPC representative list, consistent with Article 48 UPCA. UPC representation in patent litigation therefore requires advance registration. Industry observers expect the UPC Registrar to continue refining admission requirements as case volumes increase. Practitioners should verify their registration status well ahead of any planned UPC action.

Common Pitfalls in Chemical Patent Prosecution and How to Avoid Them

• Insufficient experimental disclosure. The description fails to enable the full breadth of the claims, particularly for Markush-type claims. Remedy: include representative working examples across the claimed range, provide reproducibility data, and avoid overbroad structural generics unsupported by evidence.
• Public disclosure before priority filing. Conference presentations, pre-print publications or investor materials destroy novelty. Remedy: enforce internal confidentiality protocols, require signed confidentiality agreements for all external collaborators, and if accidental disclosure occurs, file a provisional application immediately.
• Missing the EPO opposition or unitary request window. The 9-month opposition period and the 1-month unitary request period run from mention of grant and cannot be extended. Remedy: maintain an automated docketing system with alerts set well before each deadline.
• Over-reliance on post-filed test data. Post-filed experimental data at the EPO can corroborate but cannot establish an inventive step that was not already made plausible in the application as filed. Remedy: structure claims so that the as-filed specification contains sufficient data to make the technical effect plausible without relying on later experiments.
• Failing to coordinate divisional strategy with UPC opt-outs. A divisional that is not opted out may be subject to central revocation at the UPC, undermining the purpose of preserving alternative claim sets. Remedy: involve litigation counsel when planning divisional filings and record opt-outs promptly where appropriate.
• Underestimating opposition and UPC litigation costs. Chemistry-heavy oppositions and UPC proceedings routinely involve expert testing, comparative experiments and translation costs that exceed initial budgets. Remedy: establish realistic litigation reserves early, and evaluate early settlement or mediation options where the commercial case supports them.

Conclusion: A Practical Roadmap for How to Prosecute a Chemical Patent in the Netherlands

Prosecuting a chemical patent in the Netherlands and at the EPO in 2026 demands disciplined attention to disclosure standards, filing strategy, deadline management and post-grant enforcement choices. The 2026 legislative and procedural updates, from Dutch Patent Act proposals to EPO Guideline revisions and UPC representation clarifications, add urgency to getting each step right. Use the procedural steps, document checklists, timeline tables and pitfall warnings in this guide as your working framework. For advice tailored to your specific chemical invention or enforcement situation, find an IP lawyer with specialist experience in chemistry prosecution, EPO oppositions and UPC litigation.

Sources

1. European Patent Office, Oppositions
2. EPO Guidelines / 2026 Unitary Patent Guidelines
3. Unified Patent Court, Rules of Procedure
4. Netherlands Enterprise Agency (RVO), Patents
5. epi, Are You a UPC Representative? (2026)